Christopher G Azzoli MD FASCO
Thoracic Cancer
Director of Thoracic Oncology, Lifespan Cancer Institute; Associate Professor of Medicine, Brown University
Join to View Full Profile
Lifespan Cancer Institute593 Eddy Street, George 362Providence, RI 02903
Fax+1 401-444-4184
Dr. Azzoli is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
RI State Medical License 2018 - 2028
MA State Medical License 2012 - 2027
NY State Medical License 1999 - 2013
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC Start of enrollment: 2005 Nov 01
- Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer Start of enrollment: 2003 Jan 01
- Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer Start of enrollment: 2002 Mar 01
Publications & Presentations
PubMed
- Molecular Characterization of Pericardial Mesothelioma With Constrictive and Recurrent Pericarditis: TAZ Amplification and Hippo Pathway.Ryan Tudino, Shelby Smith, Liang Cheng, Katharine French, Christopher Azzoli
JACC. Case Reports. 2025-11-26 - 2 citationsWorldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.Wafik S El-Deiry, Catherine Bresson, Fanny Wunder, Benedito A Carneiro, Don S Dizon
Oncotarget. 2025-03-12 - 6 citationsTRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury.Jillian Strandberg, Anna Louie, Seulki Lee, Marina Hahn, Praveen Srinivasan
The Journal of Clinical Investigation. 2025-01-14
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationR S Heist, Z Piotrowska, C G Azzoli, A T Shaw, I T Lennes, L V Sequist, J F Gainor, Oxford University Press
Press Mentions
Roche’s IMpower010 Trial Results Warrant Evidence on Survival Impact for Tecentriq Adoption in Non-Small Cell Lung CancerJune 2nd, 2021
Merck’s Proposed Less Frequent Keytruda Dosing May Allow for Minor Uptake BoostNovember 19th, 2019
Committees
- Member (Steering committee), Update Committee of the ASCO NSCLC Expert Panel, American Society of Clinical Oncology 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
